{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:439260",
      "entity_text" : "norepinephrine",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "cellosaurus:CVCL_E992" ],
      "Species" : [ "taxonomy:55581" ],
      "TissueType" : [ "tissuelist:TS-0808" ],
      "Organ" : [ "uberon:UBERON:0000120" ]
    }
  },
  "verbose_text" : "Another conopeptide based drug candidate, xen2174 (from Xenome Ltd., Brisbane, Australia), increases norepinephrine levels in the spinal cord.",
  "reading_complete" : "2020-08-08T19:15:39Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T19:09:38Z",
  "trigger" : "levels",
  "evidence" : [ "norepinephrine levels" ],
  "pmc_id" : "4009767",
  "score" : 0
}